SECTOR GAMMA AS

Institutional manager (13F) · CIK 1475373

13F holdings · as of 2026-03-31 · top 42 · reported portfolio $423M

#	Issuer	Value	Shares
1	BRISTOL-MYERS SQUIBB CO	$50M	827,901
2	MERCK & CO INC	$31M	260,340
3	PFIZER INC	$31M	1,091,385
4	MEDTRONIC PLC	$24M	280,682
5	INCYTE CORP	$19M	200,510
6	AMGEN INC	$17M	47,155
7	BIOGEN INC	$17M	90,096
8	ZIMMER BIOMET HOLDINGS INC	$14M	155,835
9	BIOMARIN PHARMACEUTICAL INC	$14M	239,918
10	BECTON DICKINSON & CO	$13M	82,615
11	ELEVANCE HEALTH INC FORMERLY	$13M	43,962
12	IONIS PHARMACEUTICALS INC	$13M	169,468
13	CARDINAL HEALTH INC	$12M	54,897
14	UNITEDHEALTH GROUP INC	$10M	36,435
15	CVS HEALTH CORP	$10M	135,337
16	BRUKER CORP	$9M	254,010
17	GE HEALTHCARE TECHNOLOGIES I	$9M	126,418
18	ABBOTT LABS	$9M	87,532
19	GILEAD SCIENCES INC	$7M	53,247
20	LANTHEUS HLDGS INC	$7M	93,344
21	IQVIA HLDGS INC	$7M	40,230
22	SYNDAX PHARMACEUTICALS INC	$7M	286,007
23	BIO RAD LABS INC	$7M	23,750
24	QIAGEN NV	$7M	162,371
25	AVANTOR INC	$5M	695,403
26	CENTENE CORP DEL	$5M	162,405
27	TANDEM DIABETES CARE INC	$5M	267,091
28	PTC THERAPEUTICS INC	$5M	75,000
29	LABCORP HOLDINGS INC	$5M	19,019
30	ASCENDIS PHARMA A/S	$5M	21,305
31	EDWARDS LIFESCIENCES CORP	$5M	60,402
32	DEXCOM INC	$4M	56,122
33	CRINETICS PHARMACEUTICALS IN	$3M	94,195
34	KURA ONCOLOGY INC	$3M	411,810
35	HUMANA INC	$3M	19,202
36	BRIDGEBIO PHARMA INC	$3M	44,263
37	IOVANCE BIOTHERAPEUTICS INC	$3M	900,000
38	DENALI THERAPEUTICS INC	$3M	162,710
39	ARDELYX INC	$3M	516,131
40	COGENT BIOSCIENCES INC	$3M	80,000
41	ORGANON & CO	$2M	375,974
42	ARROWHEAD PHARMACEUTICALS IN	$2M	30,000

Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.